Cognitive Impairment Following Cardiac Arrest and Target Temperature Management

NCT01946932 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 287

Last updated 2013-12-05

No results posted yet for this study

Summary

This is a steering group approved substudy to the Target Temperature Management trial (TTM, ClinicalTrials.gov Identifier: NCT01020916). TTM compares the effect of two strictly controlled temperature regimes for survivors of out-of-hospital cardiac arrest.

The primary aim of this sub-study is to compare the amount of cognitive impairment in cardiac arrest survivors treated with 33 degrees and 36 degrees and with a matched group of control patients with myocardial infarction.

Our secondary aims are:

* To investigate the impact of cognitive impairment on our patients' ability to participate in society and their health related quality of life.
* To investigate the relationship between our patients cognitive impairments and their relatives/informants health related quality of life and feelings of burden.
* To test the hypothesis that the simple cognitive screening battery used in the TTM main trial is sensitive enough to detect all patients with significant cognitive disability.

Conditions

  • Heart Arrest
  • Out-of-hospital Cardiac Arrest
  • Cognition Disorders
  • Brain Injury

Interventions

OTHER

Temperature treatment

Sponsors & Collaborators

  • Lund University

    collaborator OTHER
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER
  • Copenhagen University Hospital, Denmark

    collaborator OTHER
  • Azienda Ospedaliera Santa Maria Degli Angeli

    collaborator OTHER
  • Copenhagen Trial Unit, Center for Clinical Intervention Research

    collaborator OTHER
  • University Hospital of Wales

    collaborator OTHER
  • Region Skane

    lead OTHER

Principal Investigators

  • Tobias Cronberg, MD, PhD · Department of Clinical Sciences, Lund University, Lund, Sweden and Department of Neurology, Skåne University Hospital, Lund, Sweden

  • Niklas Nielsen, MD,PhD · Department of Clinical Sciences, Lund University, Lund Sweden and Department of Anesthesia and Intensive Care, Helsingborg Hospital, Helsingborg, Sweden

  • Jesper Kjaergaard, MD, PhD · The Heart Centrem Copenhagen University, Copenhagen, Denmark

  • Janneke Horn, MD, PhD · Department of Intensive Care, Academic Medical Centrum, Amsterdam, Netherlands

  • Tommaso Pellis, MD, PhD · Intensive Care Unit Santa Maria Degli Angeli, Pordenonde, Italy

  • Matthew P Wise, MD, PhD · Adult Critical Care, University Hospital of Wales, Cardiff, Untied Kingdom

  • Gisela Lilja, OT · Lund University Hospital, Lund, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • Denmark
  • Italy
  • Netherlands
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01946932 on ClinicalTrials.gov